Euclidean Capital LLC Tenaya Therapeutics, Inc. Transaction History
Euclidean Capital LLC
- $779 Million
- Q1 2024
A detailed history of Euclidean Capital LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Euclidean Capital LLC holds 1,015,705 shares of TNYA stock, worth $4.28 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
1,015,705
Previous 1,015,705
-0.0%
Holding current value
$4.28 Million
Previous $3.29 Million
61.46%
% of portfolio
0.68%
Previous 0.37%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
90Shares Held
47.2MCall Options Held
35.8KPut Options Held
1.1K-
Column Group LLC San Francisco, CA9.4MShares$39.6 Million30.64% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$28.3 Million2.84% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$19.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.35MShares$14.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.86MShares$12.1 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $174M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...